JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHS
2876
DELISTED
Innophos Holdings, Inc.
IPHS
| $2.86M | ﹤0.01% |
116,795
-258
| -0.2% | -$7.84K |
|
2877
Rithm Capital
RITM
$5.52B
| $2.86M | ﹤0.01% |
201,041
+40,096
| +25% | +$677K |
|
2878
Grand Canyon Education
LOPE
$3.85B
| $2.85M | ﹤0.01% |
29,701
-86,110
| -74% | -$10M |
|
|
MLPI
2879
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $2.85M | ﹤0.01% |
144,410
+5,518
| +4% | +$121K |
|
2880
CALL
Costco
COST
$422B
| $2.85M | ﹤0.01% |
14,000
-3,400
| -20% | -$759K |
|
|
DCOM
2881
DELISTED
Dime Community Bancshares
DCOM
| $2.85M | ﹤0.01% |
167,805
-9,510
| -5% | -$162K |
|
2882
Liberty Global Class A
LBTYA
$3.62B
| $2.85M | ﹤0.01% |
133,491
-9,332
| -7% | -$229K |
|
|
QEP
2883
DELISTED
QEP RESOURCES, INC.
QEP
| $2.85M | ﹤0.01% |
505,411
+58,866
| +13% | +$517K |
|
2884
Healthcare Services Group
HCSG
$1.6B
| $2.84M | ﹤0.01% |
70,748
+3,518
| +5% | +$149K |
|
2885
CALL
Qorvo
QRVO
$7.99B
| $2.84M | ﹤0.01% |
+46,800
| New | +$3.15M |
|
|
ITCI
2886
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.84M | ﹤0.01% |
249,400
+32,168
| +15% | +$519K |
|
2887
Surgery Partners
SGRY
$2.01B
| $2.84M | ﹤0.01% |
289,827
+124,990
| +76% | +$1.68M |
|
2888
Dorchester Minerals
DMLP
$1.33B
| $2.83M | ﹤0.01% |
193,686
-17,078
| -8% | -$298K |
|
2889
Golub Capital BDC
GBDC
$3.34B
| $2.83M | ﹤0.01% |
175,313
+86,821
| +98% | +$1.54M |
|
2890
CALL
Stryker
SYK
$125B
| $2.82M | ﹤0.01% |
18,000
+800
| +5% | +$134K |
|
|
2891
PUT
Stryker
SYK
$125B
| $2.82M | ﹤0.01% |
+18,000
| New | +$3.01M |
|
2892
CALL
Sysco
SYY
$40.8B
| $2.82M | ﹤0.01% |
+45,000
| New | +$3.03M |
|
|
2893
PUT
Sysco
SYY
$40.8B
| $2.82M | ﹤0.01% |
+45,000
| New | +$3.03M |
|
|
CLVS
2894
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.82M | ﹤0.01% |
156,942
-319,549
| -67% | -$6.53M |
|
2895
Cohen & Steers
CNS
$4.23B
| $2.81M | ﹤0.01% |
81,980
-24,032
| -23% | -$889K |
|
2896
KRONOS Worldwide
KRO
$693M
| $2.81M | ﹤0.01% |
243,974
+147,609
| +153% | +$1.99M |
|
2897
Verastem
VSTM
$510M
| $2.81M | ﹤0.01% |
69,643
+68,317
| +5,152% | +$4.17M |
|
|
LHCG
2898
DELISTED
LHC Group LLC
LHCG
| $2.81M | ﹤0.01% |
29,905
+20,101
| +205% | +$1.92M |
|
2899
Teekay
TK
$1.01B
| $2.81M | ﹤0.01% |
840,131
+121,119
| +17% | +$664K |
|
|
XYZ
2900
CALL
Block Inc
XYZ
$48.4B
| $2.81M | ﹤0.01% |
+50,000
| New | +$3.53M |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.